Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents

BACKGROUND: Studies on temporal changes in noninvasive fibrosis indices and liver stiffness measurement (LSM) in patients with chronic hepatitis C (CHC) treated with direct-acting antiviral agents (DAAs) are limited. METHODS: We retrospectively enrolled consecutive patients with CHC who had received...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Wei-Fan, Lai, Hsueh-Chou, Su, Wen-Pang, Lin, Chia-Hsin, Chuang, Po-Heng, Chen, Sheng-Hung, Chen, Hung-Yao, Wang, Hung-Wei, Huang, Guan-Tarn, Peng, Cheng-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486982/
https://www.ncbi.nlm.nih.gov/pubmed/31029101
http://dx.doi.org/10.1186/s12876-019-0973-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486982/
https://www.ncbi.nlm.nih.gov/pubmed/31029101
http://dx.doi.org/10.1186/s12876-019-0973-5

Ejemplares similares